Starfish Of Sweden

Redefining Pressure Ulcer Prevention One of healthcare's most persistent and costly challenges is being reimagined—starting with the skin. At Starfish of Sweden, we are proud to introduce a patented innovation platform designed to prevent the development of pressure ulcers before they occur. Our solution is grounded in scientific evidence, with studies showing superior clinical effect compared to currently available alternatives. The Innovation Our platform addresses a widely accepted, yet inefficient reality: pressure ulcer care is reactive, repetitive, and expensive. Starfish offers a preventive system that promotes and maintains healthy skin conditions—minimizing patient risk and relieving pressure on care systems. This is not a single product—it's a scalable product ecosystem, built to meet the needs of patients and caregivers across various high-risk environments. The Market Potential Pressure ulcers affect millions of patients globally every year and represent billions in healthcare costs. This is a problem not limited to hospitals—elderly care, home care, and even non-medical sectors such as aviation and mobility face similar risks. By focusing on prevention rather than treatment, Starfish is positioned to set a new standard across multiple industries. The potential impact is not only clinical, but also economic and organizational. The Business Model We operate through a scalable licensing model, enabling rapid market access via partnerships with established players across sectors. This gives us flexibility, reach, and the ability to focus on continuous product innovation. Where We Are Today Starfish is backed by a strong owner base, protected by global IP, and has now entered its commercialization phase. With proven technology and growing market interest, we are actively seeking partners to help us scale. Join us in transforming pressure ulcer care—from reactive to preventive. Learn more: www.starfishofsweden.se

• Employees 7
• Founded 2020